S100B and Parkinson disease: Power analysis had been conducted beforehand based on publicly available data in order to determine sample size for confirmatory cohort I. The univariate analysis revealed six protein candidates being significantly dysregulated in early clinical PD patients compared to controls: Aβ42, t-Tau, p-Tau, α-syn, DJ-1 and S100β.